MedPath

BOEHRINGER INGELHEIM FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

104

Active:104
Completed:0

Trial Phases

1 Phases

Phase 1:89

Drug Approvals

7

NMPA:7

Drug Approvals

Meloxicam Injection

Product Name
莫比可
Approval Number
国药准字HJ20150538
Approval Date
Jul 21, 2020
NMPA

Meloxicam Injection

Product Name
莫比可
Approval Number
国药准字HJ20150536
Approval Date
Jul 21, 2020
NMPA

Meloxicam Injection

Product Name
莫比可
Approval Number
国药准字HJ20150537
Approval Date
Jul 21, 2020
NMPA

Bisacodyl Enteric-coated Tablets

Product Name
比沙可啶肠溶片
Approval Number
国药准字J20150010
Approval Date
Feb 3, 2015
NMPA

Bisacodyl Enteric-coated Tablets

Product Name
比沙可啶肠溶片
Approval Number
H20140831
Approval Date
Nov 3, 2014
NMPA

Bisacodyl Enteric-coated Tablets

Product Name
比沙可啶肠溶片
Approval Number
H20140832
Approval Date
Nov 3, 2014
NMPA

Bisacodyl Enteric-coated Tablets

Product Name
比沙可啶肠溶片
Approval Number
H20140830
Approval Date
Nov 3, 2014
NMPA

Clinical Trials

Distribution across different clinical trial phases (89 trials with phase data)• Click on a phase to view related trials

Phase 1
89 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.